コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 Egr-1 (early growth response gene-1) is an immediate ear
2 Egr-1 and Sp1 binding site inactivation or Egr-1 and Sp1
3 Egr-1 bound to the GC-rich SPUR activation element in th
4 Egr-1 exhibited marked induction in livers of SHP-/- mic
5 Egr-1 increased the transcription of HB-EGF (epidermal g
6 Egr-1 is a master transcription factor mediating the exp
7 Egr-1 is a potential therapeutic target for AD.
8 Egr-1 is an inducible transcription factor that recogniz
9 Egr-1 mRNA and protein were transiently induced by HNF4a
10 Egr-1 null mice were protected from diet-induced obesity
11 Egr-1 promoter was activated by E2F1, and the activation
12 Egr-1 regulates tau phosphorylation and Abeta synthesis
13 Egr-1 silencing also reduces levels of beta-secretase 1
14 Egr-1 silencing does not affect levels of cyclin-depende
15 Egr-1 was up-regulated by IGFBP-5 in a MAPK-dependent ma
16 xpression of early growth response factor 1 (Egr-1), a master transcription factor that regulates the
21 ulation of the early growth response gene-1 (Egr-1), an apparent negative transcriptional factor for
22 ne product, early growth response protein 1 (Egr-1), to examine the functional role of these vasopres
23 for genes encoding early growth response 1 (Egr-1) (transcriptional regulator), cyclooxygenase 2 (CO
25 ranscription factor early growth response 1 (Egr-1) regulates various vascular pathologies and is up-
27 tween activation of early growth response-1 (Egr-1) and atherosclerosis and also has demonstrated tha
28 ranscription factor early growth response-1 (Egr-1) and enhanced induction of genes encoding the Egr-
29 on the induction of early growth response-1 (Egr-1) and phosphorylation of c-Jun--known mediators of
34 ade involving E2F1, early growth response-1 (Egr-1), nuclear receptor small heterodimer partner (SHP,
37 of ASMCs(Des-/-) hypertrophy by the Erk-1/2/Egr-1/miR-26a/GSK-3beta pathway is consistent in human r
38 f the five selected genes-CD25 (IL-2Ralpha), Egr-1, Fosl-1, SOCS3, and Irf-4-was confirmed at the pro
43 In cells containing altered p53 activity, Egr-1 expression was abolished by pharmacological inhibi
44 BD proteins can block them and thereby allow Egr-1 to avoid sequestration in non-functional locations
46 immediate early genes (IEGs) Arc/Arg3.1 and Egr-1 in the lateral amygdala (LA) and impairs the 'cons
48 xtracellular signal-regulated kinase 1/2 and Egr-1 appears to be involved in the increased expression
49 on and transcription repression of Bcl-2 and Egr-1, which are downstream targets of ATF5 in C6 and U8
50 ctor (BDNF), a known inducer of DARPP-32 and Egr-1 expression, enhanced Egr-1 binding to H10 in vitro
51 xhibit significantly less ERK activation and Egr-1 expression in both bone marrow and testis in respo
52 d cocaine-induced phospho-ERK activation and Egr-1/Zif268 induction, but without effect on the cocain
54 e H/R-induced ROS level, JNK activation, and Egr-1 expression in H9c2 cells in a dose-dependent manne
55 and Sp1 mRNA and nuclear protein content and Egr-1 and Sp1 protein-DNA binding complex formation.
56 cell development, including Pax-5, E2A, and Egr-1, are reduced, while Id1 and Id2 are increased in F
57 he NAc is required for activation of ERK and Egr-1/Zif268 in D1 dopaminoceptive neurons after acute c
58 Egr-1 by TGF-beta in normal fibroblasts, and Egr-1 was required for stimulation of collagen by Bcr-Ab
60 mory-related immediate early genes c-Fos and Egr-1 were normalized or upregulated in hippocampal CA1
61 i1 directly bound to and repressed c-Fos and Egr-1, as has been shown for Egr-2, all of which are the
64 ion of mitogen-activated protein kinases and Egr-1 pathways, culminating ultimately into increased ex
65 ated cocaine-induced ERK phosphorylation and Egr-1/Zif268 upregulation in D1-medium spiny neurons and
67 city, learning, and memory formation such as Egr-1, Arc1, and BDNF specifically in the cerebral corte
68 crease in PKCepsilon promoter methylation at Egr-1 and Sp-1 binding sites, leading to PKCepsilon gene
72 knockdown of BACE-1 almost completely blocks Egr-1-induced amyloidogenic APP processing and Abeta syn
73 ing BACE-1 action, on the other hand, blocks Egr-1-induced amyloidogenic APP processing but does not
74 ow that ERK1/2 activity is required for both Egr-1 and CREB DNA binding to their cognate sequences id
78 AMP-response element-binding protein (CREB), Egr-1, and Sp1 transcription factors and that CREB-bindi
79 hows that in prostate cell lines in culture, Egr-1 overexpression correlated with an alteration of p5
80 nase (MAPK) are essential for ATF5-dependent Egr-1 activation and cell proliferation and survival.
81 k-1 phosphorylation abrogates ATF5-dependent Egr-1 activation and cell proliferation and survival.
86 differentiation via modulation of a Mek1/Erk/Egr-1 regulatory axis may be useful in designing new the
88 suggest that the domain dynamics facilitate Egr-1's intersegment transfer that involves transient br
89 ved the early-immediate transcription factor Egr-1 (early growth response 1), a key regulator of prof
90 of the early-immediate transcription factor Egr-1 in situ without also blocking the activation of Sm
92 n (I/R) injury, and the transcription factor Egr-1 is a master switch for various damage pathways dur
95 e up-regulation of the transcription factors Egr-1 and c-Fos and the correlated synthesis of key proi
97 MT gene activation and transcription factors Egr-1 and Sp1 in adrenal medulla-derived PC12 cells.
99 sion, our study revealed control network for Egr-1 expression through a feedback loop between SHP and
101 phorylation of CBP at Ser436 is required for Egr-1 to activate Lhb expression and is a requirement fo
102 these studies suggest an important role for Egr-1, which, by repressing FOXC2 expression, promotes e
103 together, these data reveal novel roles for Egr-1 as a negative regulator of both CCl(4)-induced hep
104 decoy oligodeoxyribonucleotides specific for Egr-1 and CREB, we discovered that Egr-1 and CREB are di
105 gnificantly reduced vascular transcripts for Egr-1 and matrix metalloproteinase (MMP)-2 antigen and a
106 that Gfi1-mediated downregulation of c-Fos, Egr-1 and Egr-2 may contribute to the role of Gfi1 in gr
107 that Gfi1 inhibits the expression of c-Fos, Egr-1 and Egr-2 through direct transcriptional repressio
108 resulted in diminished expression of c-Fos, Egr-1 and Egr-2, and partially rescued the neutrophil de
109 that Gfi1 inhibited the expression of c-Fos, Egr-1 and Egr-2, and rescued neutrophil development in c
110 e in vitro observations, induction of c-Fos, Egr-1, and BDNF was attenuated in the D1 cortical barrel
111 ction of immediate early genes (IEGs) c-Fos, Egr-1, and Homer 1a in the amygdala and the nucleus accu
112 tivation of ERK and the expression of c-Fos, Egr-1, Arc, and brain-derived neurotrophic factor (BDNF)
115 with nuclear translocation of the early gene Egr-1 In conclusion, specific and strictly ordered epige
116 eport activation of the immediate-early gene Egr-1 in the lateral amygdala (LA), hippocampus (CA1), a
119 via EP(4) activated the EGFR --> ERK1/2 --> Egr-1 pathway, leading to increased Id-1 transcription a
120 CS-Rapgef2 expression on cAMP-dependent ERK->Egr-1/Zif268 signaling in cultured neuroendocrine cells;
127 ibroblasts was accompanied by an increase in Egr-1 and YB-1 repressor binding, suggesting that the mo
129 auses a time- and dose-dependent increase in Egr-1 protein and mRNA levels and enhanced transcription
130 pecific predator odour leads to increases in Egr-1 expression in the AON in a subregion specific mann
134 -/-) cells; thus, these genes, which include Egr-1 and Egr-2, represent candidate mediators of positi
140 oprecipitation assay, which showed increased Egr-1 binding to the HIF-1alpha promoter in response to
141 m patients with scleroderma showed increased Egr-1 levels, which were highest in early diffuse diseas
142 te shock training, Pre rats showed increased Egr-1 mRNA in the prelimbic mPFC relative to Alt-Pre rat
148 2 inactivation and decreased IGFBP-3-induced Egr-1 expression block the autocrine and paracrine loops
155 histone H4 acetylation, and that PMA induced Egr-1 and ATF-2 binding to the ACE promoter, whereas Ets
156 Our findings indicate that IL-13 induces Egr-1 nuclear accumulation and CREB serine phosphorylati
163 g was impaired, and skin fibroblasts lacking Egr-1 showed reduced migration and myofibroblast transdi
164 we show that the hippocampus of mice lacking Egr-1 displays electrophysiology properties and ultrastr
165 or basal regulation of EPO via AT1R-mediated Egr-1 activation by p21Ras-mitogen-activated protein kin
168 dy provides a new therapeutic target, namely Egr-1, for attenuation of elevated leukotriene levels in
173 in the fibrotic response, delineate a novel Egr-1-dependent intracellular signaling mechanism that u
175 MAPK signaling and the induction of nuclear Egr-1 that interacts with IGFBP-5 and promotes fibrotic
176 replication is by repressing the ability of Egr-1 (early growth response-1) to bind and activate the
177 Our studies revealed sustained activation of Egr-1 with subsequent induction of its downstream target
180 f the specific complex indicated that all of Egr-1's three zinc fingers are equally involved in bindi
188 dence that histamine regulates expression of Egr-1 in mammalian cells and demonstrate a novel role of
191 on, acetylation, and prolonged expression of Egr-1 leading to proinflammatory and prothrombotic respo
196 eover, we observed that tissue expression of Egr-1 was elevated in patients with scleroderma, which s
199 mice expressing a dominant negative form of Egr-1, which lacks the trans activation domain but retai
200 activity was necessary for the induction of Egr-1 by TGF-beta in normal fibroblasts, and Egr-1 was r
201 lular regulatory mechanism: LPA induction of Egr-1 expression is via LPA cognate receptor (LPA recept
203 ation, we have also investigated kinetics of Egr-1's translocation between two nonspecific DNA duplex
211 ppocampal primary neurons, overexpression of Egr-1 induces BACE-1 expression, activates BACE-1, promo
214 site and within the gene promoter region of Egr-1 (early growth response protein 1) specifically in
215 IP-2, IL-17A did not affect up-regulation of Egr-1 by TCA, indicating that IL-17A does not affect bil
218 sential for hypoxia-stimulated regulation of Egr-1, at least in part through protein kinase C betaII,
221 tly, these results suggest a central role of Egr-1 in histamine-induced gene expression and in histam
224 mechanism that underlies the stimulation of Egr-1, demonstrate for the first time sustained Egr-1 up
225 erall, a lower sensitivity to NT in terms of Egr-1 reactivity in the maternal state was highlighted a
227 involves ERK1/2-mediated transactivation of Egr-1, which in turn increases the secretion of EGFR lig
228 nscription factors, whereas transcription of Egr-1 and Fosl-1 was induced by the MEK-ERK pathway.
229 In particular, the zinc finger 1 (ZF1) of Egr-1 in the nonspecific complex is mainly dissociated f
230 Egr-1 and Sp1 binding site inactivation or Egr-1 and Sp1 siRNA inhibit PNMT promoter stimulation by
231 , did not change the levels of CREB, Sp1, or Egr-1 binding to the Galphas promoter, but it induced a
232 igenetic mechanism in fibrogenesis and place Egr-1 upstream in TGF-beta-driven stimulation of p300 ge
234 Our current study of the zinc-finger protein Egr-1 (also known as Zif268) and its nuclease derivative
237 On the contrary, HNF4alpha siRNA reduced Egr-1 expression at both the mRNA and protein levels, an
240 regulatory mechanism: histamine up-regulates Egr-1 expression in primary HAECs via the H1 receptor an
242 uctal gray, virgin mice showed a significant Egr-1 increase with NT (relative to vehicle), but matern
243 overlapping binding consensus sites for SP1, Egr-1, and AP-2), bases C(-71) and C(-59), and an NFkapp
245 st, transgenic mice with fibroblast-specific Egr-1 overexpression showed exuberant tissue repair, wit
247 -1, demonstrate for the first time sustained Egr-1 up-regulation in fibrotic lesions and suggests tha
251 cific for Egr-1 and CREB, we discovered that Egr-1 and CREB are directly involved in regulating 15-LO
256 in immunoprecipitation assay identified that Egr-1, AP-2, and NFkappaB bind to the promoter in HYAL-1
257 tin immunoprecipitation assays indicate that Egr-1 and Sp-1 mediate TSA-induced NAG-1 expression.
262 nal analysis of FGF-2 promoter revealed that Egr-1 binding site proximal to transcription start site
263 e results point to the fundamental role that Egr-1 plays in the regulation of transforming growth fac
266 tional activation of BACE-1 and suggest that Egr-1 plays role in activation of BACE-1 and acceleratio
268 tivities of Cdk5 and BACE-1, suggesting that Egr-1 is a potential therapeutic candidate for the treat
269 lation in fibrotic lesions and suggests that Egr-1 has a role in the induction and progression of fib
270 tients with scleroderma, which suggests that Egr-1 may be involved in tissue repair and fibrosis.
271 lear factor 4alpha (HNF4alpha) activated the Egr-1 promoter through three DR1 response elements as id
275 and enhanced induction of genes encoding the Egr-1-regulated proinflammatory chemokines monocyte chem
276 ay in the target association process for the Egr-1 zinc-finger protein is the one involving intersegm
277 RNA levels and enhanced transcription of the Egr-1 gene via serum response elements in normal fibrobl
278 ARE and serum response element (SRE) of the Egr-1 promoter, which facilitates binding of extracellul
280 ing induced the nuclear translocation of the Egr-1 transcription factor, and overexpression of domina
281 e measured the target search kinetics of the Egr-1 zinc-finger protein at various ionic strengths bet
282 pp, we have studied the translocation of the Egr-1 zinc-finger protein in the target DNA association
285 a activity, as well as its enrichment on the Egr-1 promoter, were markedly repressed by small heterod
286 ion of E2F1, SHP, and EID1 proteins with the Egr-1 promoter, and their direct protein interactions we
289 t mediate ERK and JNK activation, leading to Egr-1 expression, we found that LPA-induced activation o
291 ws structural and functional similarities to Egr-1, these two related early-immediate transcription f
292 wild-type p53 was not sufficient to trigger Egr-1 transcription, four different mutants of p53 were
293 n Bim promoter region, while E1A upregulated Egr-1, which was directly involved in Bim transactivatio
294 prove zinc-finger technology, which has used Egr-1 (Zif268) as a major scaffold for engineering.
296 ein constitutively are growth inhibited when Egr-1 is down-regulated by negative signals from BCR or
297 aspects of the DNA-scanning process in which Egr-1 is nonspecifically bound to DNA and perpetually ch
298 e stimulation, AhR was found in complex with Egr-1 and activator protein-2, which are 2 other nuclear
299 ding protein (CBP) is known to interact with Egr-1, the major mediator of GNRH action on the Lhb gene
300 CBP at Ser436 increased the interaction with Egr-1 on the Lhb promoter, loss of this phosphorylation